These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7731548)
21. Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes. García-Sanz A; Badia A; Clos MV Synapse; 2001 Apr; 40(1):65-73. PubMed ID: 11170223 [TBL] [Abstract][Full Text] [Related]
22. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats. Konieczny J; Lenda T; Czarnecka A Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686 [TBL] [Abstract][Full Text] [Related]
23. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway. Andrés ME; Gysling K; Bustos G Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143 [TBL] [Abstract][Full Text] [Related]
24. Opioid modulation of amphetamine-stimulated dopamine release and concentration in rat striatal slices. Kolta MG; Bardo MT Pharmacol Biochem Behav; 1993 Dec; 46(4):819-25. PubMed ID: 8309961 [TBL] [Abstract][Full Text] [Related]
25. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. Lucas G; Spampinato U J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521 [TBL] [Abstract][Full Text] [Related]
27. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
28. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR; Johnson KM J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468 [TBL] [Abstract][Full Text] [Related]
29. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats. See RE; Murray CE Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895 [TBL] [Abstract][Full Text] [Related]
30. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. Cass WA; Zahniser NR J Neurochem; 1991 Jul; 57(1):147-52. PubMed ID: 1828829 [TBL] [Abstract][Full Text] [Related]
31. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices. Zazpe A; Artaiz I; Del Río J Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893 [TBL] [Abstract][Full Text] [Related]
32. 17β-Estradiol infusions into the dorsal striatum rapidly increase dorsal striatal dopamine release in vivo. Shams WM; Sanio C; Quinlan MG; Brake WG Neuroscience; 2016 Aug; 330():162-70. PubMed ID: 27256507 [TBL] [Abstract][Full Text] [Related]
33. Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms. Holson RR; Gazzara RA; Gough B Brain Res; 1998 Oct; 808(2):182-9. PubMed ID: 9767162 [TBL] [Abstract][Full Text] [Related]
34. Striatal interaction among dopamine, glutamate and ascorbate. Morales I; Fuentes A; Ballaz S; Obeso JA; Rodriguez M Neuropharmacology; 2012 Dec; 63(8):1308-14. PubMed ID: 22959966 [TBL] [Abstract][Full Text] [Related]
35. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia. See RE Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693 [TBL] [Abstract][Full Text] [Related]
36. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181 [TBL] [Abstract][Full Text] [Related]
37. Modulation of dopamine release by striatal 5-HT2C receptors. Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911 [TBL] [Abstract][Full Text] [Related]
38. Adenosine A1 receptors mediate hypoxia-induced inhibition of electrically evoked transmitter release from rat striatal slices. Jin S; Fredholm BB Eur J Pharmacol; 1997 Jun; 329(2-3):107-13. PubMed ID: 9226401 [TBL] [Abstract][Full Text] [Related]
39. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Okada M; Mizuno K; Kaneko S Neurosci Lett; 1996 Jul; 212(1):53-6. PubMed ID: 8823761 [TBL] [Abstract][Full Text] [Related]
40. D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. Memo M; Missale C; Carruba MO; Spano PF Neurosci Lett; 1986 Nov; 71(2):192-6. PubMed ID: 2878398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]